Prosper Trading Academy Blog

January 15, 2019

A Cancer Breakthrough?

Kitov Pharma Ltd (KTOV) was up strongly in trading today due to news regarding one of its products. NT219, which is in a preclinical study, was found to demonstrate a strong anti-cancer effect. The new data revealed that even with a short exposure of cancerous cells to NT219, the drug was sufficient to trigger an irreversible shutdown of cancer pathways. As a result, significant interest in the stock was generated today, with volumes well over 50 million shares. Here’s a recap.

about the author:

Mike Patton

Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker, he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.